JP2001515712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001515712A5 JP2001515712A5 JP2000510770A JP2000510770A JP2001515712A5 JP 2001515712 A5 JP2001515712 A5 JP 2001515712A5 JP 2000510770 A JP2000510770 A JP 2000510770A JP 2000510770 A JP2000510770 A JP 2000510770A JP 2001515712 A5 JP2001515712 A5 JP 2001515712A5
- Authority
- JP
- Japan
- Prior art keywords
- april
- use according
- blocking agent
- suppressing
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002981 blocking agent Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5878697P | 1997-09-12 | 1997-09-12 | |
| US60/058,786 | 1997-09-12 | ||
| US7938498P | 1998-03-26 | 1998-03-26 | |
| US60/079,384 | 1998-03-26 | ||
| PCT/US1998/019191 WO1999012965A2 (en) | 1997-09-12 | 1998-09-11 | April- a novel protein with growth effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001515712A JP2001515712A (ja) | 2001-09-25 |
| JP2001515712A5 true JP2001515712A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=26738027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000510770A Pending JP2001515712A (ja) | 1997-09-12 | 1998-09-11 | 増殖効果を有する新規タンパク質−april |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20030138884A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1027431A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001515712A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100618492B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1195849C (cg-RX-API-DMAC7.html) |
| AU (1) | AU759717B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9812634A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2303615A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ294615B6 (cg-RX-API-DMAC7.html) |
| EA (1) | EA005411B1 (cg-RX-API-DMAC7.html) |
| EE (1) | EE200000147A (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0004611A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL134537A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS5378A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20001242L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ503850A (cg-RX-API-DMAC7.html) |
| PL (1) | PL339463A1 (cg-RX-API-DMAC7.html) |
| SK (1) | SK3542000A3 (cg-RX-API-DMAC7.html) |
| TR (1) | TR200000669T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999012965A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
| US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
| US6440694B1 (en) * | 1997-09-30 | 2002-08-27 | Pharmacia & Upjohn Company | TNF-related death ligand |
| WO1999026976A1 (en) * | 1997-11-26 | 1999-06-03 | Eli Lilly And Company | Tnf ligand family gene |
| WO2001060397A1 (en) * | 2000-02-16 | 2001-08-23 | Genentech, Inc. | Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
| US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
| CZ299819B6 (cs) | 1999-01-25 | 2008-12-03 | Biogen Idec Ma Inc. | Farmaceutické kompozice obsahující protilátky specifické pro rozpustný BAFF |
| US20030022233A1 (en) | 1999-04-30 | 2003-01-30 | Raymond G. Goodwin | Methods of use of the taci/taci-l interaction |
| HK1043608B (en) * | 1999-08-17 | 2007-12-07 | Biogen Ma Inc. | Baff receptor (bcma), an immunoregulatory agent |
| WO2001025256A2 (en) * | 1999-10-06 | 2001-04-12 | University Of Utah Research Foundation | Trdl-1-gamma, a novel tumor necrosis-like ligand |
| UA74798C2 (uk) * | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
| EP1259544B1 (en) | 2000-02-11 | 2011-08-24 | Biogen Idec MA Inc. | Heterologous polypeptide of the tnf family |
| AU2006201471B2 (en) * | 2000-02-16 | 2009-07-23 | Genentech, Inc. | Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| AU2001263114A1 (en) * | 2000-05-12 | 2001-11-26 | Amgen Inc | Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| EP1294949A4 (en) * | 2000-06-15 | 2004-08-25 | Human Genome Sciences Inc | HUMAN TUMORNESCROSE FACTOR DELTA AND EPSILON |
| UA83458C2 (uk) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
| GB2370273A (en) * | 2000-12-20 | 2002-06-26 | Viaxxel Biotech Gmbh | Compounds that affect CD83 expression |
| US7189820B2 (en) | 2001-05-24 | 2007-03-13 | Human Genome Sciences, Inc. | Antibodies against tumor necrosis factor delta (APRIL) |
| PL403488A1 (pl) | 2001-05-24 | 2013-07-08 | Zymogenetics, Inc. | Zastosowanie bialka fuzyjnego TACI-immunoglobulina, bialko fuzyjne, czasteczka kwasu nukleinowego kodujaca bialko fuzyjne, kompozycja farmaceutyczna i sposób wytwarzania bialka fuzyjnego TACI-immunoglobulina |
| US7381792B2 (en) | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
| US7399829B2 (en) | 2002-01-04 | 2008-07-15 | Xencor, Inc. | Variants of RANKL protein |
| US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
| WO2004089982A2 (en) * | 2003-01-06 | 2004-10-21 | Xencor | April variants and methods thereof |
| EP1608730B1 (en) | 2003-03-28 | 2013-11-06 | Biogen Idec MA Inc. | Truncated baff receptors |
| WO2005075511A1 (en) * | 2004-01-29 | 2005-08-18 | Genentech, Inc. | Variants of the extracellular domain of bcma and uses thereof |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| WO2005113598A2 (en) * | 2004-05-21 | 2005-12-01 | Xencor, Inc. | Tnf super family members with altered immunogenicity |
| AU2005318086B2 (en) | 2004-12-23 | 2011-07-07 | Merck Serono Sa | BCMA polypeptides and uses thereof |
| US8808696B2 (en) | 2005-08-09 | 2014-08-19 | Ares Trading S.A. | Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules |
| KR20080056714A (ko) | 2005-08-09 | 2008-06-23 | 지모제넥틱스, 인코포레이티드 | TACI―Ig 융합 분자를 사용하여 B―세포 악성종양을치료하는 방법 |
| CA2623530C (en) | 2005-09-26 | 2015-02-03 | Apotech Corporation | Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| KR20080074120A (ko) | 2005-10-13 | 2008-08-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물 |
| CA2629306A1 (en) | 2005-11-23 | 2007-05-31 | Genentech, Inc. | Methods and compositions related to b cell assays |
| WO2007134326A2 (en) | 2006-05-15 | 2007-11-22 | Ares Trading S.A. | Methods for treating autoimmune diseases using a taci-ig fusion molecule |
| WO2010100056A2 (en) | 2009-03-02 | 2010-09-10 | Stichting Top Institute Pharma | Antibodies against a proliferating inducing ligand (april) |
| EP2542679A1 (en) * | 2010-03-05 | 2013-01-09 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | B-cell stimulating fusion proteins of an antigen with baff or april |
| WO2011109280A1 (en) | 2010-03-05 | 2011-09-09 | Lerner Research Institute | Methods and compositions to treat immune-mediated disorders |
| NL2011406C2 (en) | 2013-09-06 | 2015-03-10 | Bionovion Holding B V | Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides. |
| HRP20231121T1 (hr) * | 2013-09-23 | 2023-12-22 | Regeneron Pharmaceuticals, Inc. | Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale |
| GB201317929D0 (en) * | 2013-10-10 | 2013-11-27 | Ucl Business Plc | Chimeric antigen receptor |
| US20150143559A1 (en) * | 2013-11-19 | 2015-05-21 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized a proliferation-inducing ligand gene |
| NL2014108B1 (en) | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
| US20170145086A1 (en) | 2015-11-25 | 2017-05-25 | Visterra, Inc. | Antibody molecules to april and uses thereof |
| JP2023548866A (ja) | 2020-10-29 | 2023-11-21 | インダストリアル ポリマーズ アンド ケミカルズ, インコーポレイテッド | 病原体監視及び不活性化のエアフィルター |
| CA3228678A1 (en) | 2021-08-11 | 2023-02-16 | Amato J. Giaccia | Methods of reducing production of iga, igm and/or igg using sbcma variants and fc fusion proteins thereof |
| TW202440636A (zh) | 2023-03-21 | 2024-10-16 | 美商傳記55有限公司 | Cd19/cd38多特異性抗體 |
| CN118909083A (zh) * | 2024-07-30 | 2024-11-08 | 江苏省农业科学院 | 一种猪b细胞增殖诱导配体蛋白及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5176996A (en) * | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5256775A (en) * | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| US5264564A (en) * | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| WO1996040774A1 (en) * | 1995-06-07 | 1996-12-19 | Biogen, Inc. | Complexes of modified lymphotoxins as pharmaceutical preparations |
| US6509170B1 (en) * | 1996-03-14 | 2003-01-21 | Human Genome Sciences, Inc. | Polynucleotides encoding human tumor necrosis factor delta |
| DE69630710T2 (de) * | 1996-03-14 | 2004-09-23 | Human Genome Sciences Inc. | Humaner tumornekrosefaktor delta und epsilon |
| US6171787B1 (en) * | 1997-06-26 | 2001-01-09 | Abbott Laboratories | Member of the TNF family useful for treatment and diagnosis of disease |
-
1998
- 1998-09-11 PL PL98339463A patent/PL339463A1/xx unknown
- 1998-09-11 CN CNB988090384A patent/CN1195849C/zh not_active Expired - Fee Related
- 1998-09-11 WO PCT/US1998/019191 patent/WO1999012965A2/en not_active Ceased
- 1998-09-11 CA CA002303615A patent/CA2303615A1/en not_active Abandoned
- 1998-09-11 IL IL13453798A patent/IL134537A0/xx unknown
- 1998-09-11 TR TR2000/00669T patent/TR200000669T2/xx unknown
- 1998-09-11 NZ NZ503850A patent/NZ503850A/xx unknown
- 1998-09-11 EA EA200000310A patent/EA005411B1/ru unknown
- 1998-09-11 CZ CZ2000869A patent/CZ294615B6/cs not_active IP Right Cessation
- 1998-09-11 KR KR1020007002577A patent/KR100618492B1/ko not_active Expired - Fee Related
- 1998-09-11 AU AU93162/98A patent/AU759717B2/en not_active Ceased
- 1998-09-11 EE EEP200000147A patent/EE200000147A/xx unknown
- 1998-09-11 JP JP2000510770A patent/JP2001515712A/ja active Pending
- 1998-09-11 BR BR9812634-2A patent/BR9812634A/pt not_active Application Discontinuation
- 1998-09-11 EP EP98946066A patent/EP1027431A2/en not_active Withdrawn
- 1998-09-11 SK SK354-2000A patent/SK3542000A3/sk unknown
- 1998-09-11 HU HU0004611A patent/HUP0004611A3/hu unknown
-
2000
- 2000-02-18 IS IS5378A patent/IS5378A/is unknown
- 2000-03-09 NO NO20001242A patent/NO20001242L/no unknown
-
2002
- 2002-05-01 US US10/138,073 patent/US20030138884A1/en not_active Abandoned
-
2004
- 2004-02-12 US US10/778,890 patent/US20050112596A1/en not_active Abandoned
-
2005
- 2005-12-06 US US11/296,049 patent/US20060084148A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| WO2004062604A3 (en) | Treatment of cancer with 2-deoxyglucose | |
| TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
| PL287844A1 (en) | Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases | |
| HK1043313A1 (zh) | 用於治疗癌症的多西他赛和rhumab her2 | |
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| CA2334267A1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
| CA2214503A1 (en) | Method for treating tumors | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| IL161889A (en) | Use of omega interferon in the manufacture of a medicament for treating viral disease | |
| WO2003049694A3 (en) | Methods of therapy for non-hodgkin's lymphoma | |
| JP2004537500A5 (cg-RX-API-DMAC7.html) | ||
| WO2000040229A3 (en) | Synergistic tumorcidal response induced by histamine | |
| WO2000008007A3 (de) | Cyclopentabenzofuran-derivate und ihre verwendung | |
| JP2002530353A5 (cg-RX-API-DMAC7.html) | ||
| Zein | Interferons in the management of viral hepatitis | |
| EP1561462A3 (en) | Anti arrhytmic composition and methods of treatment | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| MY105798A (en) | Treatment of leukocyte dysfunction with gm-csf. | |
| EP0795332A3 (en) | Medical use of gamma-interferon in interstitial lung diseases | |
| Corazziari | Need of the ideal drug for the treatment of chronic constipation | |
| EA199800770A1 (ru) | Лекарственный препарат для терапевтического лечения вирусного гепатита | |
| TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
| WO2001045642A3 (en) | Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease | |
| JP2002520292A5 (ja) | ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントbの使用 |